Abstract
This study investigates the relationship between serum homocysteine (Hcy) levels and embryo quality in women with Diminished Ovarian Reserve (DOR) undergoing IVF/ICSI. Analyzing 1,023 patients, researchers found that elevated Hcy and advanced maternal age are independent risk factors for poor embryo quality. A predictive model combining these factors was developed to assist clinicians in estimating the probability of acquiring high-quality embryos.
Introduction
Diminished Ovarian Reserve (DOR) is a significant challenge in reproductive medicine, characterized by a decrease in both the quantity and quality of oocytes. For women with DOR, Assisted Reproductive Technology (ART) often results in poor ovarian response and low embryo quality. While homocysteine (Hcy)—a sulfur-containing amino acid—has been linked to infertility in conditions like Polycystic Ovary Syndrome (PCOS), its role in DOR was previously unclear. This study aims to determine if Hcy levels can serve as a metabolic marker for embryo quality in this high-challenge population.
Methodology
This retrospective cohort study analyzed records from the Dalian Municipal Women and Children’s Medical Center (2015–2020). From an initial pool of 12,978 IVF/ICSI cycles, 1,023 patients were selected based on strict DOR criteria, including FSH ≥ 10 mIU/ml, AMH < 1.1 ng/ml, or AFC < 7.
Patients were categorized into two groups:
- High-quality embryo group (n=540): At least one high-quality embryo.
- Poor-quality embryo group (n=483): Zero high-quality embryos.
Embryos were graded on a 1–4 scale based on blastomere equality, morphology, and fragmentation. High-quality embryos (Grades 1-2) were defined as having more than six cells and minimal fragmentation on Day 3.
Results and Discussion
Hcy as a Metabolic Marker
Serum Hcy levels were significantly higher in the poor-quality embryo group (9.22 vs. 8.57 µmol/L, $P = 0.021$). This suggests that elevated Hcy may actively interfere with oocyte maturation and subsequent embryo development. Notably, patients with Hcy levels >15 µmol/L faced an 82.1% risk of poor-quality embryos, compared to 43.9% for those with levels <8 µmol/L.
Synergistic Effect of Age and Hcy
While maternal age is a well-known factor in DOR, this study identifies Hcy as an independent risk factor. Logistic regression analysis confirmed that as both age and Hcy increase, the likelihood of producing high-quality embryos decreases. The researchers developed a predictive formula to estimate outcomes:
$p = \frac{1}{1 + \exp[-(2.641 - 0.041x_1 - 0.104x_2)]}$
where $x_1$ is age and $x_2$ is Hcy.
Hormonal Environment
The high-quality embryo group also exhibited significantly higher Anti-Müllerian Hormone (AMH) and lower Prolactin (PRL) levels, highlighting the complex endocrine balance necessary for successful fertilization in DOR patients.
Conclusion
Serum Hcy level, particularly when combined with maternal age, is a valuable predictor of embryo quality in women with DOR. These findings suggest that monitoring Hcy levels could be a standard part of IVF workups for this population. Furthermore, future research should explore whether nutritional interventions, such as B-vitamin and folate supplementation to lower Hcy, can directly improve clinical outcomes for women struggling with diminished ovarian reserve.
Summary updated